NT-proBNP和hs-CRP的检测在急性冠脉综合征中的价值(2)
| 第1页 |
参见附件。
[1]Seino Y,Ogawa A,Yamashita T,et al.Application of NT-proBNP and BNP ln easu rellen is in cardiac care a more disce ming marker for tile detection and evaluation of heart failure.Eur J heart failur,2004,6(3):295-300.
[2]Omland T,Persson A,Ng L,et al.N-Teminal pro-B-Type natriu re tic peptide and long tena mortality in acute coronary syndromes.C irculation,2006,106(23):2913-2918.
[3]Meune G,Martins E,Fulla Y,et al.New biologica malkers for acutecorona ry artery,disease.J Mal Vasc,2003,28(5):251-257.
[4]OItrona L,Ardissino D,Merlini P,et al.C-reactive Prote in elevation and early outcome in patients with unstable pectoris.Am J Cardiac 2007,80(8):1002-1006.
[5]Mueller T,Gegenhuber A,Poelz W,et al.Biochem ieal diagnosis of impaired left ventrila rejection fraction comparison of the diagnostic accu racy of bra in natriu retic peptide(BNP)and am ino temlinal proBNP(NT-proBNP).Clin Chem Lab Med,2004,42(2)：159-163
[6]Pande R,Perlstein T,Beckman L，et al.Association of insul in resistance and inflammationwith peripheral arte ria disease The National Health and Nutrition Examination Survey 1999 to 2004.C irculation,2008,118(1):33-41.
[7]Kim H,Yang D,Park Y,et al.I remental Progaostic value of C Reactive prote in and N-Teminal pro-B-type natriu retie peptide in acute coronary syndrome.Circulation 2006 70(11)：1379-1384.
【收稿日期】2011-01-22
您现在查看是摘要介绍页，详见PDF附件。